Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes (Q46182652)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes |
scientific article |
Statements
1 reference
Pramlintide: a human amylin analogue reduced postprandial plasma glucose, insulin, and C-peptide concentrations in patients with type 2 diabetes (English)
1 reference
R G Thompson
1 reference
A Gottlieb
1 reference
K Organ
1 reference
J Koda
1 reference
J Kisicki
1 reference
O G Kolterman
1 reference
1 July 1997
1 reference
1 reference
14
1 reference
7
1 reference
547-555
1 reference